SETD2 and cancer: Beyond its role in cancer progression through pathways such as NF- κ B, AKT/GSK3 β , PI3K/Akt/mTOR and HIF-1 α , promoting epithelial-mesenchymal transition (EMT), tumor survival and metastasis, CNPY2 is also critical in non-cancer conditions.